Most Recent Articles by Marc Iskowitz
When Monique Levy, one of the most-level-headed analysts in the pharma industry, calls attention to a mysterious phenomenon, you listen.
Long-time practice lead Gil Bashe is tasked with unifying and building the health function at global firm Finn Partners.
Apple's ResearchKit could accelerate the pace at which industry approaches start-ups building products in the patient-facing part of health tech
Haymarket purchased HCP-engagement specialist Group DCA and will operate the digital agency out of its custom medical communications division.
How should pharma organize around adjacencies to therapeutics?
More Articles by Marc Iskowitz
Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.